TP53 and acute myeloid leukemia: Recurrent genetic alterations in AML-EMD, including complex karyotypes and pathogenic mutations in TP53, JAK2, and GATA1 mutations found in AML-EMD, were associated with early erythroid and MEP/megakaryocytic progenitor differentiation states.